title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,SYRS,0.00644,Neutral,-0.002652
"Tesla, Twitter And 76 Biggest Movers From Friday",20220711T113029,https://www.benzinga.com/news/22/07/28014980/tesla-twitter-and-76-biggest-movers-from-friday,SYRS,0.028388,Somewhat-Bullish,0.156634
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket,20220804T105117,https://www.benzinga.com/news/22/08/28349800/why-is-yellow-trading-higher-by-33-here-are-48-stocks-moving-premarket,SYRS,0.059562,Neutral,0.049096
"The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More",20220516T133825,https://www.benzinga.com/general/biotech/22/05/27217168/the-week-ahead-in-biotech-may-16-21-gene-cell-therapy-conference-presentations-tapering-earnings-,SYRS,0.122362,Neutral,0.000636
"Earnings Scheduled For May 16, 2022",20220516T091844,https://www.benzinga.com/news/earnings/22/05/27212365/earnings-scheduled-for-may-16-2022,SYRS,0.033321,Neutral,-0.11902
Syros  ( SYRS )  Rises on Upbeat Initial Study Data on Tamibarotene,20231207T144400,https://www.zacks.com/stock/news/2194793/syros-syrs-rises-on-upbeat-initial-study-data-on-tamibarotene,SYRS,0.136499,Somewhat-Bullish,0.225812
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,SYRS,0.021778,Neutral,-0.020221
